Tumor escape mechanisms in prostate cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 1, p. 81, doi. 10.1007/s00262-005-0110-x
- By:
- Publication type:
- Article
Works matching IS 03407004 AND DT 2007 AND VI 56 AND IP 1
Results: 13
1
2
Recoverin as a cancer-retina antigen.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 1, p. 110, doi. 10.1007/s00262-006-0132-z
- By:
- Publication type:
- Article
3
Lymphocyte activation in response to melanoma: interaction of NK-associated receptors and their ligands.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 1, p. 101, doi. 10.1007/s00262-006-0141-y
- By:
- Publication type:
- Article
4
Impact of KIR/HLA ligand combinations on immune responses in malignant melanoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 1, p. 95, doi. 10.1007/s00262-006-0151-9
- By:
- Publication type:
- Article
5
The role of CD4+ T cell help in cancer immunity and the formulation of novel cancer vaccines.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 1, p. 70, doi. 10.1007/s00262-006-0154-6
- By:
- Publication type:
- Article
6
Tumor-derived CD4<sup>+</sup>CD25<sup>+</sup> regulatory T cell suppression of dendritic cell function involves TGF- β and IL-10.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 1, p. 48, doi. 10.1007/s00262-006-0160-8
- By:
- Publication type:
- Article
7
Co-expression of α(1,3)galactosyltransferase and Bacillus thuringiensis PIPLC enhances hyperacute rejection of tumor cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 1, p. 25, doi. 10.1007/s00262-006-0163-5
- By:
- Publication type:
- Article
8
Effects of interferon gamma on native human acute myelogenous leukaemia cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 1, p. 13, doi. 10.1007/s00262-006-0159-1
- By:
- Publication type:
- Article
9
Identification of different tumor escape mechanisms in several metastases from a melanoma patient undergoing immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 1, p. 88, doi. 10.1007/s00262-006-0166-2
- By:
- Publication type:
- Article
10
Treatment with HPMA copolymer-based doxorubicin conjugate containing human immunoglobulin induces long-lasting systemic anti-tumour immunity in mice.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 1, p. 35, doi. 10.1007/s00262-006-0168-0
- By:
- Publication type:
- Article
11
DC-based vaccine loaded with acid-eluted peptides in acute myeloid leukemia: the importance of choosing the best elution method.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 1, p. 1, doi. 10.1007/s00262-006-0170-6
- By:
- Publication type:
- Article
12
Immunotherapy of renal cell carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 1, p. 117, doi. 10.1007/s00262-006-0172-4
- By:
- Publication type:
- Article
13
Complement insufficiency limits efficacy in a xenograft model of hyperacute rejection for cancer therapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 1, p. 60, doi. 10.1007/s00262-006-0174-2
- By:
- Publication type:
- Article